|
1
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Song YX, Yue ZY, Wang ZN, Xu YY, Luo Y, Xu
HM, Zhang X, Jiang L, Xing CZ and Zhang Y: MicroRNA-148b is
frequently down-regulated in gastric cancer and acts as a tumor
suppressor by inhibiting cell proliferation. Mol Cancer. 10:12011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zuberi M, Khan I, Mir R, Gandhi G, Ray PC
and Saxena A: Utility of Serum miR-125b as a diagnostic and
prognostic indicator and its alliance with a panel of tumor
suppressor genes in epithelial ovarian cancer. PLoS One.
11:e01539022016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kinose Y, Sawada K, Nakamura K and Kimura
T: The role of microRNAs in ovarian cancer. Biomed Res Int.
2014:2493932014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tilghman SL, Rhodes LV, Bratton MR,
Carriere P, Preyan LC, Boue SM, Vasaitis TS, McLachlan JA and Burow
ME: Phytoalexins, miRNAs and breast cancer: A review of
phytochemical-mediated miRNA regulation in breast cancer. J Health
Care Poor Underserved. 24 (Suppl 1):S36–S46. 2013. View Article : Google Scholar
|
|
6
|
Chen J, Deng S, Zhang S, Chen Z, Wu S, Cai
X, Yang X, Guo B and Peng Q: The role of miRNAs in the
differentiation of adipose-derived stem cells. Curr Stem Cell Res
Ther. 9:268–279. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Du L, Borkowski R, Zhao Z, Ma X, Yu X, Xie
XJ and Pertsemlidis A: A high-throughput screen identifies miRNA
inhibitors regulating lung cancer cell survival and response to
paclitaxel. RNA Biol. 10:1700–1713. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He J, Zhang JF, Yi C, Lv Q, Xie WD, Li JN,
Wan G, Cui K, Kung HF, Yang J, et al: miRNA-mediated functional
changes through co-regulating function related genes. PLoS One.
5:e135582010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Recchiuti A and Serhan CN: Pro-resolving
lipid mediators (SPMs) and their actions in regulating miRNA in
novel resolution circuits in inflammation. Front Immunol.
3:2982012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wolff LJ, Wolff JA and Sebestyén MG:
Effect of tissue-specific promoters and microRNA recognition
elements on stability of transgene expression after hydrodynamic
naked plasmid DNA delivery. Hum Gene Ther. 20:374–388. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xia JH, He XP, Bai ZY and Yue GH:
Identification and characterization of 63 MicroRNAs in the Asian
seabass Lates calcarifer. PLoS One. 6:e175372011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vos S, Vesuna F, Raman V, van Diest PJ and
van der Groep P: miRNA expression patterns in normal breast tissue
and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation
carriers. Oncotarget. 6:32115–32137. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mushtaq G, Greig NH, Anwar F, Zamzami MA,
Choudhry H, Shaik MM, Tamargo IA and Kamal MA: miRNAs as
circulating biomarkers for Alzheimer's disease and Parkinson's
disease. Med Chem. 12:217–225. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ren X, Bai X, Zhang X, Li Z, Tang L, Zhao
X, Li Z, Ren Y, Wei S, Wang Q, et al: Quantitative nuclear
proteomics identifies that miR-137-mediated EZH2 reduction
regulates resveratrol-induced apoptosis of neuroblastoma cells. Mol
Cell Proteomics. 14:316–328. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang LG, Ni Y, Su BH, Mu XR, Shen HC and
Du JJ: MicroRNA-34b functions as a tumor suppressor and acts as a
nodal point in the feedback loop with Met. Int J Oncol. 42:957–962.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aure MR, Leivonen SK, Fleischer T, Zhu Q,
Overgaard J, Alsner J, Tramm T, Louhimo R, Alnæs GI, Perälä M, et
al: Individual and combined effects of DNA methylation and copy
number alterations on miRNA expression in breast tumors. Genome
Biol. 14:R1262013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qin W, Zhang K, Clarke K, Weiland T and
Sauter ER: Methylation and miRNA effects of resveratrol on mammary
tumors vs. Nutr Cancer. 66:270–277. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schwarzenbach H, Nishida N, Calin GA and
Pantel K: Clinical relevance of circulating cell-free microRNAs in
cancer. Nat Rev Clin Oncol. 11:145–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu J, Cao Z, Liu W, You L, Zhou L, Wang C,
Lou W, Sun B, Miao Y, Liu X, et al: Plasma miRNAs effectively
distinguish patients with pancreatic cancer from controls: A
multicenter study. Ann Surg. 263:1173–1179. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park SM, Gaur AB, Lengyel E and Peter ME:
The miR-200 family determines the epithelial phenotype of cancer
cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes
Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Long ZH, Bai ZG, Song JN, Zheng Z, Li J,
Zhang J, Cai J, Yao HW, Wang J, Yang YC, et al: miR-141 inhibits
proliferation and migration of colorectal cancer SW480 Cells.
Anticancer Res. 37:4345–4352. 2017.PubMed/NCBI
|
|
22
|
van Jaarsveld MT, Helleman J, Boersma AW,
van Kuijk PF, van Ijcken WF, Despierre E, Vergote I, Mathijssen RH,
Berns EM, Verweij J, et al: miR-141 regulates KEAP1 and modulates
cisplatin sensitivity in ovarian cancer cells. Oncogene.
32:4284–4293. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou X, Su J, Zhu L and Zhang G:
Helicobacter pylori modulates cisplatin sensitivity in gastric
cancer by down-regulating miR-141 expression. Helicobacter.
19:174–181. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fu WF, Chen WB, Dai L, Yang GP, Jiang ZY,
Pan L, Zhao J and Chen G: Inhibition of miR-141 reverses cisplatin
resistance in non-small cell lung cancer cells via upregulation of
programmed cell death protein 4. Eur Rev Med Pharmacol Sci.
20:2565–2572. 2016.PubMed/NCBI
|
|
25
|
Wang D, Ma J, Ji X, Xu F and Wei Y:
miR-141 regulation of EIF4E expression affects docetaxel
chemoresistance of non-small cell lung cancer. Oncol Rep.
37:608–616. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tejero R, Navarro A, Campayo M, Viñolas N,
Marrades RM, Cordeiro A, Ruíz-Martínez M, Santasusagna S, Molins L,
Ramirez J and Monzó M: miR-141 and miR-200c as markers of overall
survival in early stage non-small cell lung cancer adenocarcinoma.
PLoS One. 9:e1018992014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim YH, Kim JH, Kim H, Kim H, Lee YC, Lee
SK, Shin SK, Park JC, Chung HS, Park JJ, et al: Is the recent WHO
histological classification for gastric cancer helpful for
application to endoscopic resection? Gastric Cancer. 19:869–875.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sen Z, Zhan XK, Jing J, Yi Z and Wanqi Z:
Chemosensitizing activities of cyclotides from Clitoria ternatea in
paclitaxel-resistant lung cancer cells. Oncol Lett. 5:641–644.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang S, Xin H, Li Y, Zhang D, Shi J, Yang
J and Chen X: Skimmin, a coumarin from hydrangea paniculata, slows
down the progression of membranous glomerulonephritis by
Anti-inflammatory effects and inhibiting immune complex deposition.
Evid Based Complement Alternat Med. 2013:8192962013.PubMed/NCBI
|
|
31
|
Kontomanolis EN and Koukourakis MI:
MicroRNA: The potential regulator of endometrial carcinogenesis.
Microrna. 4:18–25. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fan Y, Zhou Y, Zhou X, Sun F, Gao B, Wan
M, Zhou X, Sun J, Xu X, Cheng L, et al: MicroRNA 224 regulates ion
transporter expression in ameloblasts to coordinate enamel
mineralization. Mol Cell Biol. 35:2875–2890. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hu Y, Xu K and Yagüe E: miR-218 targets
survivin and regulates resistance to chemotherapeutics in breast
cancer. Breast Cancer Res Treat. 151:269–280. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li Q, Zhu F and Chen P: miR-7 and miR-218
epigenetically control tumor suppressor genes RASSF1A and Claudin-6
by targeting HoxB3 in breast cancer. Biochem Biophys Res Commun.
424:28–33. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang L, Xu Q, Xie H, Gu G and Jiang J:
Expression of serum miR-218 in hepatocellular carcinoma and its
prognostic significance. Clin Transl Oncol. 18:841–847. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang Z, Song Q, Yang S, Zeng R, Li X,
Jiang C, Ding W, Zhang J and Zheng Y: Serum microRNA-218 is a
potential biomarker for esophageal cancer. Cancer Biomark.
15:381–389. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xin SY, Feng XS, Zhou LQ, Sun JJ, Gao XL
and Yao GL: Reduced expression of circulating microRNA-218 in
gastric cancer and correlation with tumor invasion and prognosis.
World J Gastroenterol. 20:6906–6911. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang XL, Shi HJ, Wang JP, Tang HS, Wu YB,
Fang ZY, Cui SZ and Wang LT: MicroRNA-218 is upregulated in gastric
cancer after cytoreductive surgery and hyperthermic intraperitoneal
chemotherapy and increases chemosensitivity to cisplatin. World J
Gastroenterol. 20:11347–11355. 2014. View Article : Google Scholar : PubMed/NCBI
|
